USC Stevens INI launches a $3 million study to solve some puzzles about Parkinson’s disease

usc stevens ini launches a 3 million study to solve some puzzles about parkinsons disease

Sumary of USC Stevens INI launches a $3 million study to solve some puzzles about Parkinson’s disease:

  • The USC Mark and Mary Stevens Neuroimaging and Informatics Institute (USC Stevens INI), part of the Keck School of Medicine of USC, has launched a $3 million study that will unite researchers and data from 20 countries to answer some of the most pressing questions about Parkinson’s disease (PD).
  • This new grant will tackle some of the major puzzles about how PD progresses in the brain, and how treatment can protect against those changes.
  • Thompson, PhD, principal investigator of the new initiative and associate director, USC Stevens INI The researchers have already conducted one of the largest internationally coordinated analyses of PD brain imaging data.
  • Researchers will also investigate genetic factors that contribute to PD risk, with a particular focus on how different genes increase the risk of developing PD in individuals with European versus Asian ancestry.
  • Related StoriesThe grant funds researchers who are collecting data in historically understudied regions, including Taiwan, South Africa, and Siberia.
  • Thompson will lead the effort in conjunction with Kathleen Poston, MD, of Stanford University and Ysbrand van der Werf, PhD, of Amsterdam University Medical Centers in the Netherlands.
  • ENIGMA-PD builds on the success of the Enhancing Neuro Imaging Genetics through Meta-Analysis (ENIGMA) consortium, which unites neuroimaging researchers in 45 countries to study a variety brain diseases and processes.

Want to know more click here go to source.

From -

Close

Site Language


By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close